Home › Funds › Concorde Financial Corp › ABBV

Concorde Financial Corp position in ABBV

ABBVIE INC · Health Care

Concorde Financial Corp reported holding 27,358 shares of ABBV (ABBVIE INC) in its Q2 2026 13F filing — a position valued at US$6.9M, representing 5.55% of its reported portfolio and ranking #6 among its reported holdings. Concorde Financial Corp has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)27.36K sh
Reported value held$6.88M
Portfolio Weight5.55%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Concorde Financial Corp's ABBV position evolved

Concorde Financial Corp first disclosed a stake in ABBV in Q3 2023 at 6,700 shares (US$999K). The position peaked in Q1 2024 at 41,418 shares, worth US$7.5M. Across 12 filings, Concorde Financial Corp increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 27,358 shares valued at US$6.9M — an increase of 205 shares quarter over quarter.. Notable position changes include a 519% increase in Q4 2023 (shares rose 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.70K $998.70K New
Q4 2023 41.49K $6.43M Add
Q1 2024 41.42K $7.54M Hold
Q2 2024 33.19K $5.69M Reduce
Q3 2024 32.77K $6.47M Reduce
Q4 2024 32.90K $5.85M Hold
Q1 2025 32.80K $6.87M Hold
Q2 2025 32.70K $6.07M Hold
Q3 2025 31.79K $7.36M Reduce
Q4 2025 31.21K $7.04M Reduce
Q1 2026 27.15K $5.91M Reduce
Q2 2026 27.36K $6.88M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Concorde Financial Corp held ABBV?

Concorde Financial Corp has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Concorde Financial Corp's current position in ABBV?

As of Q2 2026, Concorde Financial Corp holds 27.36K shares of ABBV (ABBVIE INC), valued at $6.88M, representing 5.55% of its reported portfolio and ranking #6.

Has Concorde Financial Corp been buying or selling ABBV?

In the latest 13F filing (Q2 2026), Concorde Financial Corp increased its position in ABBV. The position peaked in Q1 2024 at 41.42K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.